Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
Si-Ho KimJin Yeong HongSeongman BaeHojin LeeYu-Mi WiJae-Hoon KoBomi KimEun-Jeong JooHyeri SeokHye Jin ShiJeong Rae YooMi Ri HyunHyun-Ah KimSukbin JangSeok Jun MunJungok KimMin-Chul KimDong-Sik JungSung Han KimKyong-Ran PeckPublished in: Journal of Korean medical science (2022)
Our study showed that the dose of corticosteroid use might be a risk factor for CAPA development and the possibility of CAPA contributing to adverse outcomes in critically ill COVID-19 patients.